Literature DB >> 12208981

The Epstein-Barr virus immediate-early protein BZLF1 induces both a G(2) and a mitotic block.

Amy Mauser1, Elizabeth Holley-Guthrie, Dennis Simpson, William Kaufmann, Shannon Kenney.   

Abstract

The Epstein-Barr virus immediate-early protein BZLF1 is a transcriptional activator that mediates the switch from latent to lytic infection. Here we demonstrate that BZLF1 induces both a G(2) block and a mitotic block in HeLa cells and inhibits chromosome condensation. While the G(2) block is associated with decreased cyclin B1 in host cells and can be rescued by overexpression of cyclin B1, the mechanism for the mitotic defect is as yet undetermined.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12208981      PMCID: PMC136482          DOI: 10.1128/jvi.76.19.10030-10037.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Infection with vaccinia virus alters regulation of cell cycle progression.

Authors:  A Wali; D S Strayer
Journal:  DNA Cell Biol       Date:  1999-11       Impact factor: 3.311

2.  Perturbation of cell cycle progression and cellular gene expression as a function of herpes simplex virus ICP0.

Authors:  W E Hobbs; N A DeLuca
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

3.  The disappearance of cyclins A and B and the increase in activity of the G(2)/M-phase cellular kinase cdc2 in herpes simplex virus 1-infected cells require expression of the alpha22/U(S)1.5 and U(L)13 viral genes.

Authors:  S J Advani; R Brandimarti; R R Weichselbaum; B Roizman
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosis.

Authors:  G Juan; F Traganos; W M James; J M Ray; M Roberge; D M Sauve; H Anderson; Z Darzynkiewicz
Journal:  Cytometry       Date:  1998-06-01

5.  SV40 small T antigen enhances progression to >G2 during lytic infection.

Authors:  B Whalen; J Laffin; T D Friedrich; J M Lehman
Journal:  Exp Cell Res       Date:  1999-08-25       Impact factor: 3.905

6.  Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo.

Authors:  E M Westphal; A Mauser; J Swenson; M G Davis; C L Talarico; S C Kenney
Journal:  Cancer Res       Date:  1999-04-01       Impact factor: 12.701

7.  The Epstein-Barr virus protein BRLF1 activates S phase entry through E2F1 induction.

Authors:  J J Swenson; A E Mauser; W K Kaufmann; S C Kenney
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

8.  Human cytomegalovirus 86-kilodalton IE2 protein blocks cell cycle progression in G(1).

Authors:  L Wiebusch; C Hagemeier
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

9.  Herpes simplex virus type 1 immediate-early protein Vmw110 inhibits progression of cells through mitosis and from G(1) into S phase of the cell cycle.

Authors:  P Lomonte; R D Everett
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

10.  Cyclin B2 undergoes cell cycle-dependent nuclear translocation and, when expressed as a non-destructible mutant, causes mitotic arrest in HeLa cells.

Authors:  P Gallant; E A Nigg
Journal:  J Cell Biol       Date:  1992-04       Impact factor: 10.539

View more
  19 in total

1.  Mutation of a single amino acid residue in the basic region of the Epstein-Barr virus (EBV) lytic cycle switch protein Zta (BZLF1) prevents reactivation of EBV from latency.

Authors:  Celine Schelcher; Sarah Valencia; Henri-Jacques Delecluse; Matthew Hicks; Alison J Sinclair
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

2.  The Epstein-Barr virus replication protein BBLF2/3 provides an origin-tethering function through interaction with the zinc finger DNA binding protein ZBRK1 and the KAP-1 corepressor.

Authors:  Gangling Liao; Jian Huang; Elizabeth D Fixman; S Diane Hayward
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Epstein-Barr virus BZLF1 protein binds to mitotic chromosomes.

Authors:  Amy L Adamson
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

4.  PRDM6 is enriched in vascular precursors during development and inhibits endothelial cell proliferation, survival, and differentiation.

Authors:  Yaxu Wu; James E Ferguson; Hong Wang; Rusty Kelley; Rongqin Ren; Holly McDonough; James Meeker; Peter C Charles; Hengbin Wang; Cam Patterson
Journal:  J Mol Cell Cardiol       Date:  2007-06-30       Impact factor: 5.000

5.  Contribution of C/EBP proteins to Epstein-Barr virus lytic gene expression and replication in epithelial cells.

Authors:  Jian Huang; Gangling Liao; Honglin Chen; Frederick Y Wu; Lindsey Hutt-Fletcher; Gary S Hayward; S Diane Hayward
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

6.  Epstein-Barr virus BZLF1 protein impairs accumulation of host DNA damage proteins at damage sites in response to DNA damage.

Authors:  Jie Yang; Wen Deng; Pok M Hau; Jia Liu; Victoria M Y Lau; Annie L M Cheung; Michael S Y Huen; Sai W Tsao
Journal:  Lab Invest       Date:  2015-06-01       Impact factor: 5.662

7.  Modeling early Epstein-Barr virus infection in Drosophila melanogaster: the BZLF1 protein.

Authors:  Amy L Adamson; Natasha Wright; Dennis R LaJeunesse
Journal:  Genetics       Date:  2005-08-03       Impact factor: 4.562

8.  Identification of a negative regulatory element in the Epstein-Barr virus Zta transactivation domain that is regulated by the cell cycle control factors c-Myc and E2F1.

Authors:  Zhen Lin; Qinyan Yin; Erik Flemington
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

9.  Functional interaction between Epstein-Barr virus replication protein Zta and host DNA damage response protein 53BP1.

Authors:  Sarah G Bailey; Elizabeth Verrall; Celine Schelcher; Alex Rhie; Aidan J Doherty; Alison J Sinclair
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

10.  The zipper region of Epstein-Barr virus bZIP transcription factor Zta is necessary but not sufficient to direct DNA binding.

Authors:  Matthew R Hicks; Salama S Al-Mehairi; Alison J Sinclair
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.